[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2014 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- -19.53%
YoY- 37.72%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Revenue 1,887,616 2,122,933 1,994,440 1,987,488 1,874,688 1,946,639 1,838,372 1.77%
PBT 154,448 125,580 116,968 125,562 152,636 92,997 79,986 55.12%
Tax -26,744 -31,355 -40,162 -40,356 -46,052 -36,236 -32,661 -12.48%
NP 127,704 94,225 76,805 85,206 106,584 56,761 47,325 93.94%
-
NP to SH 127,176 93,844 76,196 84,384 104,868 55,200 45,849 97.53%
-
Tax Rate 17.32% 24.97% 34.34% 32.14% 30.17% 38.96% 40.83% -
Total Cost 1,759,912 2,028,708 1,917,634 1,902,282 1,768,104 1,889,878 1,791,046 -1.16%
-
Net Worth 528,173 525,526 507,513 502,162 515,022 486,754 473,857 7.50%
Dividend
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Div 72,494 72,486 55,239 41,415 41,408 41,477 33,903 66.05%
Div Payout % 57.00% 77.24% 72.50% 49.08% 39.49% 75.14% 73.95% -
Equity
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Net Worth 528,173 525,526 507,513 502,162 515,022 486,754 473,857 7.50%
NOSH 258,908 258,880 258,935 258,846 258,805 258,911 258,938 -0.00%
Ratio Analysis
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
NP Margin 6.77% 4.44% 3.85% 4.29% 5.69% 2.92% 2.57% -
ROE 24.08% 17.86% 15.01% 16.80% 20.36% 11.34% 9.68% -
Per Share
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 729.07 820.05 770.25 767.82 724.36 751.85 709.97 1.78%
EPS 49.12 36.25 29.43 32.60 40.52 21.32 17.71 97.52%
DPS 28.00 28.00 21.33 16.00 16.00 16.02 13.09 66.09%
NAPS 2.04 2.03 1.96 1.94 1.99 1.88 1.83 7.51%
Adjusted Per Share Value based on latest NOSH - 258,914
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 130.97 147.30 138.38 137.90 130.08 135.07 127.56 1.77%
EPS 8.82 6.51 5.29 5.86 7.28 3.83 3.18 97.52%
DPS 5.03 5.03 3.83 2.87 2.87 2.88 2.35 66.16%
NAPS 0.3665 0.3646 0.3521 0.3484 0.3573 0.3377 0.3288 7.51%
Price Multiplier on Financial Quarter End Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 -
Price 6.00 4.58 4.63 4.61 4.46 4.45 4.82 -
P/RPS 0.82 0.56 0.60 0.60 0.62 0.59 0.68 13.30%
P/EPS 12.21 12.63 15.73 14.14 11.01 20.87 27.22 -41.43%
EY 8.19 7.91 6.36 7.07 9.09 4.79 3.67 70.85%
DY 4.67 6.11 4.61 3.47 3.59 3.60 2.72 43.43%
P/NAPS 2.94 2.26 2.36 2.38 2.24 2.37 2.63 7.71%
Price Multiplier on Announcement Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 18/05/15 23/02/15 21/11/14 21/08/14 14/05/14 24/02/14 19/11/13 -
Price 6.91 5.28 4.45 4.62 4.70 4.29 4.72 -
P/RPS 0.95 0.64 0.58 0.60 0.65 0.57 0.66 27.51%
P/EPS 14.07 14.57 15.12 14.17 11.60 20.12 26.66 -34.71%
EY 7.11 6.87 6.61 7.06 8.62 4.97 3.75 53.24%
DY 4.05 5.30 4.79 3.46 3.40 3.73 2.77 28.84%
P/NAPS 3.39 2.60 2.27 2.38 2.36 2.28 2.58 19.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment